After adjustment for baseline values of appetite, CRP, age, smoking, NIHSS, history of stroke, fatigue, stress, anxiety, and depression, the adjusted mean difference for appetite was 1.38 (95% CI, 0.19 to 2.56) for patients who received RJ compared to those of the placebo group. This evidence concerns the gene CRP and depressive symptom measurement.